Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants

Liis Leitsalu, Marili Palover, Timo Tõnis Sikka, Anu Reigo, Mart Kals, Kalle Pärn, Tiit Nikopensius, Tõnu Esko, Andres Metspalu, Peeter Padrik, Neeme Tõnisson
doi: https://doi.org/10.1101/2020.06.29.20139691

Article usage

Article usage: June 2020 to June 2025

AbstractFullPdf
Jun 2020162017
Jul 2020318070
Aug 2020144014
Sep 20205107
Oct 20203308
Nov 202042013
Dec 202028012
Jan 202130012
Feb 20214814
Mar 202164416
Apr 202180312
May 202164832
Jun 202156929
Jul 202135214
Aug 202131626
Sep 202130519
Oct 202135345
Nov 202125534
Dec 20212179
Jan 2022261015
Feb 202227014
Mar 202216210
Apr 202218310
May 202216316
Jun 20221756
Jul 20221131
Aug 202217511
Sep 20222869
Oct 20222028
Nov 20221414
Dec 20221055
Jan 20231155
Feb 2023843
Mar 2023655
Apr 20231955
May 2023928
Jun 2023481
Jul 2023403
Aug 202314136
Sep 20237102
Oct 2023920
Nov 20231091
Dec 2023713
Jan 2024411
Feb 20241421
Mar 20241647
Apr 2024655
May 2024200
Jun 2024224
Jul 2024833
Aug 2024333
Sep 2024929
Oct 2024875
Nov 2024602
Dec 2024414
Jan 2025722
Feb 20257283
Mar 2025182910
Apr 20257411
May 20251496
Jun 202522915
Back to top
Posted June 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants
Liis Leitsalu, Marili Palover, Timo Tõnis Sikka, Anu Reigo, Mart Kals, Kalle Pärn, Tiit Nikopensius, Tõnu Esko, Andres Metspalu, Peeter Padrik, Neeme Tõnisson
medRxiv 2020.06.29.20139691; doi: https://doi.org/10.1101/2020.06.29.20139691
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area